Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

  1. Takahashi, M.
  2. Cortés, J.
  3. Dent, R.
  4. Pusztai, L.
  5. McArthur, H.
  6. Kümmel, S.
  7. Denkert, C.
  8. Park, Y.H.
  9. Im, S.-A.
  10. Ahn, J.-H.
  11. Mukai, H.
  12. Huang, C.-S.
  13. Chen, S.-C.
  14. Kim, M.H.
  15. Jia, L.
  16. Li, X.T.
  17. Tryfonidis, K.
  18. Karantza, V.
  19. Iwata, H.
  20. Schmid, P.
Aldizkaria:
JAMA network open

ISSN: 2574-3805

Argitalpen urtea: 2023

Alea: 6

Zenbakia: 11

Orrialdeak: e2342107

Mota: Artikulua

DOI: 10.1001/JAMANETWORKOPEN.2023.42107 GOOGLE SCHOLAR